September 13, 2022
“Stocks ‘Smart Money’ Billionaires’ Are Buying Based on new or added to positions by 47 key institutional investors in the second quarter of 2022 Company Row Labels Number of portfolios added to Stock YTD % ch. Sector Eli Lilly (LLY)… Continue Reading…
May 23, 2022
“Oxfam International has a new report out today that highlights the rapidly widening gap between the few ultra-rich and the world’s poorest. The report, titled “Profiting from Pain,” found that during the first two years of the pandemic, a new billionaire was… Continue Reading…
May 20, 2022
“…According to data published by the U.S. Agriculture Department, about 80% of rented farmland is owned by investors who do not farm themselves. This ratio could increase as more investors get involved and the barriers to entry drop… Investing in… Continue Reading…
March 1, 2022
“…Enter billionaire Steven Cohen. The legendary stock picker, who began his investing career at Gruntal & Co. where he managed proprietary capital for 14 years, founded S.A.C Capital Advisors in 1992. In 2014, his investment operations were converted to Point72… Continue Reading…
August 24, 2021
“Zimmer Biomet Holdings (ZBH)… Matson’s view on ZBH is hardly an outlier, as the stock has no fewer than 13 positive reviews set in recent weeks – for a Strong Buy analyst consensus. The shares have an average price target of… Continue Reading…
May 21, 2021
“Aptiv PLC (APTV)… Based on all of the above, the analyst rates APTV an Outperform (i.e. Buy), and his $200 price target implies an upside of 46% for the coming year… In general, the rest of the Street is in agreement.… Continue Reading…
February 23, 2021
“Linde PLC (LIN)… Wall Street’s analysts are in broad agreement on the quality of Linde’s stock, as shown by the 15 Buy reviews overbalancing the 3 Holds. This gives the stock its Strong Buy analyst consensus rating. Shares are priced at… Continue Reading…
December 14, 2020
“Vertex Pharmaceuticals (VRTX)… Overall, it appears that Wall Street agrees with Tenthoff. VRTX shares have a Strong Buy analyst consensus rating, based on 14 Buys and 4 Holds. The stock’s $287.50 average price target suggests it has room for 24% growth… Continue Reading…
November 30, 2020
“G1 Therapeutics (GTHX)… Are other analysts in agreement? They are. Only Buy ratings, 3 to be exact, have been issued in the last three months. Therefore, the message is clear: GTHX is a Strong Buy. Given the $59 average price… Continue Reading…
September 24, 2020
“Mat Ishbia, a former college basketball player who’s now the chief executive officer of United Wholesale Mortgage, is set to become a billionaire after the lender his father founded said it would go public in a deal that values the… Continue Reading…
Recent Comments